Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

29 trials with published results (11%)

Research Maturity

176 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.9%

18 terminated out of 261 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

17%

44 trials in Phase 3/4

Results Transparency

16%

29 of 176 completed with results

Key Signals

29 with results91% success18 terminated

Data Visualizations

Phase Distribution

171Total
Not Applicable (75)
Early P 1 (3)
P 1 (26)
P 2 (23)
P 3 (30)
P 4 (14)

Trial Status

Completed176
Unknown32
Recruiting18
Terminated18
Not Yet Recruiting5
Withdrawn5

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 176 completed trials

Clinical Trials (261)

Showing 20 of 20 trials
NCT07002814RecruitingPrimary

Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy

NCT07562009Not ApplicableNot Yet Recruiting

Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.

NCT07447869Early Phase 1RecruitingPrimary

LYmph Node eXamination in Cat Allergen Immunotherapy

NCT07103720Phase 4CompletedPrimary

The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron

NCT06935890Phase 4RecruitingPrimary

Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

NCT07003919Phase 3RecruitingPrimary

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

NCT01923519Not ApplicableCompletedPrimary

Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects

NCT04828603RecruitingPrimary

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

NCT01305161Not ApplicableCompletedPrimary

Flow Cytometry Applied to the Diagnosis of Peri-anaesthesic Reactions

NCT06686446Not ApplicableTerminatedPrimary

Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial

NCT07400718Not ApplicableCompletedPrimary

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

NCT07402200Not ApplicableRecruitingPrimary

Study of Indoor Air Pollutants and Their Impact in Children's Health and Wellbeing

NCT04215783Active Not Recruiting

Childhood Allergy and the Neonatal Environment

NCT07309822RecruitingPrimary

Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

NCT05997784Active Not Recruiting

Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing

NCT07279467Not Yet RecruitingPrimary

Study of Oral Food Challenge Biomarkers (SAFER)

NCT05934422Not ApplicableCompleted

NiPPeR Randomised Trial - Child Follow Up Study

NCT07228325Phase 1Enrolling By Invitation

Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis

NCT06570889Phase 3Recruiting

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

NCT06560255Phase 3Recruiting

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Scroll to load more

Research Network

Activity Timeline